amgen.bio

amgen.bio is keyword-driven: the SLD "amgen" does the positioning work that a brandable would need marketing dollars for. At 5 characters the name sits in the short bucket — not ultra-premium, but comfortably in the zone where brandable startups shop. The phonetics are balanced between vowels and consonants — typical for a pronounceable English-style name. In .bio the valuation compresses toward the commercial value of the SLD itself rather than the TLD premium. The Wayback Machine has no archived snapshots of the domain, suggesting it was parked or lightly used in any prior registrations. DQS 48/100 is the mid-band: the domain has real signals behind it but isn't an obvious standout. Mid-band names reward buyers who understand a specific niche. Because the name is still in redemption (day 6 of 30), its future is largely controlled by whether the prior registrant pays the restore fee. Bottom line: evaluate this one against a specific use case you have in mind. Mid-band names don't sell themselves — they sell when the buyer is already looking.